Role of imaging in multiple myeloma

Francis I. Baffour, Katrina N. Glazebrook, Shaji K. Kumar, Stephen M. Broski

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


With rapid advancements in the diagnosis and treatment of multiple myeloma (MM), imaging has become instrumental in detection of intramedullary and extramedullary disease, providing prognostic information, and assessing therapeutic efficacy. Whole-body low dose computed tomography (WBLDCT) has emerged as the study of choice to detect osteolytic bone disease. Positron emission tomography/computed tomography (PET/CT) combines functional and morphologic information to identify MM disease activity and assess treatment response. Magnetic resonance imaging (MRI) has excellent soft-tissue contrast and is the modality of choice for bone marrow evaluation. This review focuses on the imaging modalities available for MM patient management, highlighting advantages, disadvantages, and applications of each.

Original languageEnglish (US)
Pages (from-to)966-977
Number of pages12
JournalAmerican journal of hematology
Issue number8
StatePublished - Aug 1 2020

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Role of imaging in multiple myeloma'. Together they form a unique fingerprint.

Cite this